ROBERTS EIRY (CIK 1727606) reported 12 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-04-27). Recent activity: Sell FOLD (76,275 shares), Buy FOLD (20,414 shares), Buy NBIX (2,113 shares), Sell NBIX (1,114 shares), Buy NBIX (1,120 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-04-27 | AMICUS THERAPEUTICS, INC. (FOLD) | Director | Sell | 76,275 | $1.1M |
| 2025-06-06 | AMICUS THERAPEUTICS, INC. (FOLD) | Director | Buy | 20,414 | $0 |
| 2025-02-14 | NEUROCRINE BIOSCIENCES INC (NBIX) | Chief Medical Officer | Buy | 2,113 | $0 |
| 2025-02-14 | NEUROCRINE BIOSCIENCES INC (NBIX) | Chief Medical Officer | Sell | 1,114 | $130,227 |
| 2025-02-14 | NEUROCRINE BIOSCIENCES INC (NBIX) | Chief Medical Officer | Buy | 1,120 | $0 |
| 2025-02-14 | NEUROCRINE BIOSCIENCES INC (NBIX) | Chief Medical Officer | Sell | 604 | $70,511 |
| 2025-02-14 | NEUROCRINE BIOSCIENCES INC (NBIX) | Chief Medical Officer | Buy | 1,372 | $0 |
| 2025-02-14 | NEUROCRINE BIOSCIENCES INC (NBIX) | Chief Medical Officer | Sell | 500 | $57,520 |
| 2025-02-12 | NEUROCRINE BIOSCIENCES INC (NBIX) | Chief Medical Officer | Buy | 1,860 | $0 |
| 2025-02-12 | NEUROCRINE BIOSCIENCES INC (NBIX) | Chief Medical Officer | Sell | 980 | $115,856 |
| 2025-02-04 | NEUROCRINE BIOSCIENCES INC (NBIX) | Chief Medical Officer | Buy | 2,769 | $0 |
| 2025-02-04 | NEUROCRINE BIOSCIENCES INC (NBIX) | Chief Medical Officer | Sell | 1,457 | $222,630 |
Source: SEC Form 4 filings · as of 2026-04-27